HomeInsights52 Week Low Stocks

Akums Drugs & Pharmaceuticals Ltd 52 Week Low

Akums Drugs & Pharmaceuticals Ltd 52 Week Low

stocks purchased

₹ 1.0 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

16.4 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 11, 2024

Image

Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS

YEARLOW

₹ 527

Last updated on: Dec 11, 2024

Key Highlights

  • The 52 Week Low of Akums Drugs & Pharmaceuticals Ltd is ₹ 527 as of 11 Dec 24 .

Company Fundamentals for Akums Drugs & Pharmaceuticals Ltd

No data available

Market Price of Akums Drugs & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Akums Drugs & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 2024612.45
10 Dec 2024612.45
09 Dec 2024624.55
06 Dec 2024624.35
05 Dec 2024609.05
04 Dec 2024611.65
03 Dec 2024623.65
02 Dec 2024617.3
29 Nov 2024605.4
28 Nov 2024606.45

Asset Value vs Market Value of Akums Drugs & Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Akums Drugs & Pharmaceuticals Ltd News Hub

News

Akums Drugs ties up with Jagdale Inds for marketing of ready-to-drink nutritional beverages

This collaboration exclusively focuses on aseptic manufacturing and subsequent filling in ...

Read more

26 Nov 2024 12:47

News

Akums Drugs hits life high on inking pact with Caregen

Under the agreement, Akums was granted exclusive rights to sell a selection of Caregen's p...

Read more

19 Nov 2024 12:59

News

Akums Drugs & Pharmaceuticals to conduct board meeting

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

06 Nov 2024 15:48

News

Akums Drugs signs license & distribution agreement with Triple Hair Inc.

Akums Drugs & Pharmaceuticals has entered into a License & Distribution Agreement with Tri...

Read more

16 Oct 2024 13:12

News

Akums Drugs gains on inking distribution agreement with Triple Hair Inc.

Under the terms of the agreement, the company has been granted exclusive rights to further...

Read more

16 Oct 2024 11:33

News

Akums Drugs and Pharma reports turnaround Q1 numbers

Revenue from operations was at Rs 1,019 crore in the quarter ended 30 June 2024, up 5.06% ...

Read more

26 Aug 2024 10:50

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Akums Drugs & Pharmaceuticals Ltd

Why is it important to track the 52-week low of Akums Drugs & Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Akums Drugs & Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Akums Drugs & Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Akums Drugs & Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Akums Drugs & Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Akums Drugs & Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Akums Drugs & Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Akums Drugs & Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Akums Drugs & Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Akums Drugs & Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Akums Drugs & Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Akums Drugs & Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Akums Drugs & Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions